DNAprint Genomics (DNAG)

[frogdreaming]

Virgil, That is a bit slippery don't you think? (As well as being a lie.)

I substituted no such thing, go and read your own post.

Did you not ask?

Oh wait, that would be implying that DNAPrint is capable of something that the original licensee is not. Could that be possible?

And is not..

What milestones could 'big pharma' not attain, but DNAG could?

A fair response to such a premise?

You specifically said the milestones "were not met" (NOT 'did not meet').....then you went on to say that perhaps DNAG 'could' do something that the original licensee was not capable of. Any 'sane' reader would understand you to be saying the original licensee 'could not meet' the milestone.

So here we are again, after your attempt at diversion, back to my original question.

What obstacle might 'big pharma' have encountered in their attempt to bring a blockbuster drug to market?

Remember to try to imagine something that would not qualify the following (in your own words.)

..or was it returned because there was something wrong with it then foisted off on DNAPrint as you have said so many times in the past?

regards,
frog